CRISPR Therapeutics
CRSP
#2894
Rank
A$8.35 B
Marketcap
A$87.65
Share price
3.91%
Change (1 day)
10.26%
Change (1 year)

Financial Statements

Thumbnail CRISPR Therapeutics Financial Statement 2024

Financial Statement 2024

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2022

Financial Statement 2022

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2021

Financial Statement 2021

Language: English

View Financial Statement